Nutrition and physical activity F90.0
Conditions
Interventions
Group 1: A healthy sample and patients diagnosed with ADHD/depression or at risk for a bipolar disorder participate in two face-to-face appointments, a one-week ambulatory data collection and a follow
Sponsors
Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Frankfurt
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: CoCA-PROUD: All subjects must meet DSM-5 criteria for a lifetime history of childhood onset ADHD (DSM-5 314.00, 314.01) as well as current ADHD criteria established by a specialist in the field. Diagnostic assessment is standardized according to DSM-5, by performing structured clinical interviews (SCID-I, SCID-II and DIVA in adults; K-SADS-PL in children). In addition, the ASRS and the WRAADDS are used to substantiate diagnosis in adults. - Age: 18-45 years old. - Written informed consent of the patient. - Stable TAU comprising pharmacotherapy, group based or individual cognitive behavioural therapy (not including elements of BLT or AEI). - Normal or corrected to normal vision. - Ability to understand, read, write, and speak fluently in German. - Ability to regularly and reliably attend appointments. CoCA-DA: - age: 18-50 years old. - Normal or corrected to normal vision. - Ability to understand, read, write, and speak fluently in German. - childhood onset ADHD (DSM-5 314.00, 314.01) established by a specialist in the field. In addition, ADHD questionnaires (self-report, CAARS, Wender-Utah-Skala) - chronic course (WURS-k >30 points) - additional comorbide disorder: depression (according to DSM IV), Alcohol or substance dependence (DSM-IV) or obesity (BMI>30kg/m2) CRC 1193 Z03: - healthy adults, who are fully legally competent and capable of giving informed consent. - age: 18 – 50 years - males and females - Written informed consent. BipoLife A1: Risk group 1: • help seeking young adults (age: 18-35 years) who have attended early-detection measures and who appear to have/have at least one risk factor for the development of bipolar disorder •Possible risk factors: Family history of bipolar disorder, (increasing) mood swings, subliminal hypomanic symptoms, sleep disorder, depressive syndrome Risk group 2: •ambulatory or in-patient patients with a depressive syndrome (age: 18-35 years) • Present affective symptoms in the context of the following diagnoses: •Major Depressive Disorder (MDD) •Dysthymic Disorder •Cyclothymic Disorder •Minor Depressive Disorder •Recurrent Brief Depressive Disorder •Adjustment Disorder With Depressed Mood •Depressive Disorder Not Otherwise Specified Risk group 3: •patients with AD(H)D (age: 18-35 years)
Exclusion criteria
Exclusion criteria: CoCA-PROUD: - IQ < 75 (measured by WAIS-IV vocabulary and matrix reasoning subtests) - Any severe comorbid psychiatric disorder other than the comorbid conditions explicitly studied (i.e. mood/anxiety, obesity) with necessary additional psycho-pharmacotherapy or psychiatric intervention involving day-care/inward treatment at start of study or during the study, especially a diagnosis of bipolar disorder, schizophrenia, autism spectrum disorder, schizoaffective disorder, or organic psychiatric disorder. - Any severe medical or neurological condition interfering with interventions. - Any severe medical or neurological condition not allowing BLT or AEI. - Use of antipsychotic or anti-epileptic medication, photos-sensitising medication (e.g., Lithium, St. John's Wort) -Substance use disorder (DSM-5) or dependency (DSM-5) - History of epilepsy - Acute suicidal ideation - Pregnancy - Subject is related to the investigator or study staff. - Participation in other clinical trials and observation period of competing trials. A participation in other studies is permitted if the respective study is no medication or psychotherapy trial, and if its aims do not interfere with the aims of the present study. - No patient will be allowed to enrol in this trial more than once. CoCA-DA: - Severe acute or chronic disease - Regular or acute medication intake - Exclusion criteria for a magnetic resonance imaging: pacemaker, metal fragments in the body, state after surgical procedures, the metal parts (clips, prosthesis, etc.) in the body, heart valve replacement, birth control spiral (with the exception of explicitly MRI-compatible spirals), ventricular shunt, each type of pacemaker-type devices e.g. TENS - Subject is related to the investigator or study staff. - IQ <85 - pregnancy - MRI ineligibly CRC 1193 Z03: -Lifetime diagnosis of bipolar I disorder, schizophrenia, mental disorders due to organic disease or substance dependence (excluding nicotine or cannabis dependence). - Current severe episode of other Axis 1 mental disorders. - Severe physical illness. - Lack of writing and reading skills or knowledge. - Low knowledge of the German language. - Lack of consent. - Participation in pharmaceutical studies in the last 6 months. - Tinnitus. - Non-correctable visual impairment. BipoLife A1: Risk group 1: One of the following diagnoses: •Bipolar disorder •Schizoaffective disorder •schizophrenia •sole anxiety or obsessive-compulsive symptoms •sole addictive disorder Risk group 2: One of the following diagnoses: •Bipolar disorder •Schizoaffective disorder •schizophrenia •sole anxiety or obsessive-compulsive symptoms •sole addictive disorder Risk group 3: One of the following diagnoses: •Bipolar disorder •Schizoaffective disorder •schizophrenia •sole anxiety or obsessive-compulsive symptoms •sole addictive disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Momentary impulsivity: 8 times per day for a period of 3 days through the Momentary Impulsivity Scale (MIS; Tomko et al., 2013) | — |
Secondary
| Measure | Time frame |
|---|---|
| momentary affect: 8 times per day for a period of three days through an adapted version of the MDBF (Mehrdimensionaler Befindlichkeitsfragebogen) (Wilhelm & Schoebi, 2007) | — |
Countries
Germany
Contacts
Public ContactSilke Matura
Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt
Outcome results
None listed